Paysign, Inc. Reports Fourth Quarter and Full-Year 2024 Financial Results [Yahoo! Finance]
Paysign, Inc. (PAYS)
Company Research
Source: Yahoo! Finance
Full-year 2024 net income of $3.82 million, or diluted earnings per share of $0.07, versus net income of $6.46 million, or diluted earnings per share of $0.12 for full-year 2023 Full-year 2024 Adjusted EBITDA of $9.62 million, up 43.3% from $6.71 million a year ago, while diluted Adjusted EBITDA per share was $0.17 versus $0.12 for full-year 2023 Total plasma center count increased by 16 during 2024, exiting the year with 480 centers, contributing to a 4.6% increase in plasma revenue versus the same period last year Added 33 net patient affordability programs during 2024, exiting the year with 76 active programs, leading to a 212.3% increase in pharma revenue and a 214.5% increase in pharma patient affordability revenue over the same period last year Exited the year with $10.77 million of unrestricted cash and zero debt while repurchasing 136,700 shares of common stock for $495 thousand Full-year 2024 gross dollar load volume was up 4.5% over 2023 Full-year 2024 gross spe
Show less
Read more
Impact Snapshot
Event Time:
PAYS
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
PAYS alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
PAYS alerts
High impacting Paysign, Inc. news events
Weekly update
A roundup of the hottest topics
PAYS
News
- This Paysign Insider Increased Their Holding By 25% Last Year [Yahoo! Finance]Yahoo! Finance
- PaySign Inc (PAYS) Q3 2025 Earnings Call Highlights: Record Revenue and Strategic Expansion ... [Yahoo! Finance]Yahoo! Finance
- Paysign, Inc. Just Recorded A 100% EPS Beat: Here's What Analysts Are Forecasting Next [Yahoo! Finance]Yahoo! Finance
- Paysign (NASDAQ:PAYS) had its "buy" rating reaffirmed by analysts at DA Davidson. They now have a $9.00 price target on the stock.MarketBeat
- Paysign raises 2025 revenue guidance to $81.5M while expanding patient affordability programs [Seeking Alpha]Seeking Alpha
PAYS
Sec Filings
- 12/12/25 - Form 4
- 11/13/25 - Form 10-Q
- 11/12/25 - Form 8-K
- PAYS's page on the SEC website